GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Forward PE Ratio

IDEXX Laboratories (BSP:I1DX34) Forward PE Ratio : 45.66 (As of Apr. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Forward PE Ratio?

IDEXX Laboratories's Forward PE Ratio for today is 45.66.

IDEXX Laboratories's PE Ratio without NRI for today is 49.34.

IDEXX Laboratories's PE Ratio for today is 49.58.


IDEXX Laboratories Forward PE Ratio Historical Data

The historical data trend for IDEXX Laboratories's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Forward PE Ratio Chart

IDEXX Laboratories Annual Data
Trend 2020-12 2021-12 2022-12 2023-12 2024-04
Forward PE Ratio
74.07 68.03 47.85 54.95 43.48

IDEXX Laboratories Quarterly Data
2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 8.33 11.68 9.38 74.07 64.94 75.19 75.19 68.03 57.80 36.50 38.31 47.85 57.14 50.00 42.55 54.95 49.75

Competitive Comparison of IDEXX Laboratories's Forward PE Ratio

For the Diagnostics & Research subindustry, IDEXX Laboratories's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Forward PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Forward PE Ratio falls into.



IDEXX Laboratories Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


IDEXX Laboratories  (BSP:I1DX34) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


IDEXX Laboratories Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (BSP:I1DX34) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines